Therapeutic plasma exchange protocols are being introduced to the UK via an exclusive private hospital partnership, marking the provider's first Europe expansion.
Key Takeaways
- Exclusive deal will make a private UK hospital the first to offer standardized TPE
- Company cites a randomised placebo-controlled trial reporting measurable reductions in biological age
- Company raised a reported $12 million seed round and has Khosla Ventures backing